Immune Pharmaceuticals

Listing Websites about Immune Pharmaceuticals

Filter Type:

IMMUNE PHARMACEUTICALS INC (IMNPQ) Stock Price, News

(8 days ago) Find the latest IMMUNE PHARMACEUTICALS INC (IMNPQ) stock quote, history, news and other vital information to help you with your stock trading and investing.

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Immune Pharmaceuticals Inc. LinkedIn

(Just Now) Immune Pharmaceuticals Inc. (OTCQB: IMNP) is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic …

Linkedin.com

Category:  Pharmaceutical Detail Drugs


IMNPQ Stock Price Immune Pharmaceuticals Inc. Stock

(9 days ago) IMNPQ Complete Immune Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Marketwatch.com

Category:  Pharmaceutical Detail Drugs


Immune Pharmaceuticals Inc Announces Immune

(9 days ago) Immune Pharmaceuticals Inc.'s trustee and representatives are exploring options to restructure the company with United General LTD. Adeel Ahmed, CFO and Managing partner of United General LTD, is

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Acquisition of Immune Pharmaceuticals - Yahoo

(Just Now) Immune Pharmaceuticals Inc has today received an unconditional offer by United General LTD. (UK) to acquire control of Immune Pharmaceuticals Inc.'s public company. The intent would be to reverse

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Immune Pharmaceuticals Inc Announces Immune

(1 days ago) Immune Pharmaceuticals, Inc. (IMNPQ) Proposal to Exit Bankruptcy. FORT LEE, VA / ACCESSWIRE / March 18, 2021 / Immune Pharmaceuticals Inc. (OTC PINK:IMNPQ) is in early-stage discussions with United General LTD, a UK Institutional Investment firm. Immune Pharmaceuticals Inc.'s trustee and representatives are exploring options to restructure the …

Accesswire.com

Category:  Pharmaceutical Detail Drugs


Immune Pharmaceuticals Inc Announces Immune

(9 days ago) Immune Pharmaceuticals Inc.’s trustee and representatives are exploring options to restructure the company with United General LTD. Adeel Ahmed, CFO and Managing partner of United General LTD, is leading the current discussions with Immune Pharmaceuticals Inc.

Apnews.com

Category:  Pharmaceutical Detail Drugs


Immune Pharmaceuticals Inc Announces Immune

(3 days ago) Immune Pharmaceuticals Inc. is in early-stage discussions with United General LTD, a UK Institutional Investment firm. Adeel Ahmed, CFO and Managing partner of United General LTD, is leading the

Nasdaq.com

Category:  Pharmaceutical Detail Drugs


Immune Pharmaceuticals: The Million Dollar Mistake Or

(2 days ago) On August 4 the CEO, CMO, and board chair of Immune Pharmaceuticals () reported share purchases worth a combined $1 million. Investors noticed. On August 5 the share price rose from $0.33 to $0.38

Seekingalpha.com

Category:  Pharmaceutical Detail Drugs


Fact Check: Are Pharmaceutical Companies Immune From COVID

(5 days ago) Millions of Americans have already received at least one dose of the COVID-19 vaccines, but many people wonder if pharmaceutical companies will be liable in the event of a vaccine-related injury.

Newsweek.com

Category:  Pharmaceutical Detail Drugs


Immune Pharmaceuticals - Crunchbase Company Profile & Funding

(2 days ago) Immune Pharmaceuticals Inc. (NASDAQ OMX First North Premier: IMNP; OTCQX: IMNP,) applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer.

Crunchbase.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Immune Pharmaceuticals: 5 Big Warning Signs (OTCMKTS:IMNPQ

(3 days ago) Bertilimumab trials appear to be stalled. Bertilimumab patents are set to expire by 2022, close to the drug's projected launch date.

Seekingalpha.com

Category:  Health Detail Drugs


Immune Pharmaceuticals - New York, New York, United States

(9 days ago) IMMUNE Pharmaceuticals is an Israeli-based emerging leader in the development of Monoclonal Antibodies for the treatment of Inflammatory Diseases and Cancer.

Linkedin.com

Category:  Pharmaceutical,  Cancer Detail Drugs


IMNPQ Immune Pharmaceuticals Inc. Stock Price & News - WSJ

(4 days ago) News Immune Pharmaceuticals Inc.IMNPQ. No news for IMNPQ in the past two years. The Price to Earnings (P/E) ratio, a key valuation measure, is …

Wsj.com

Category:  Pharmaceutical Detail Drugs


Acquisition of Immune Pharmaceuticals

(4 days ago) Immune Pharmaceuticals Inc has today received an unconditional offer by United General LTD. (UK) to acquire control of Immune Pharmaceuticals Inc.'s public company. The intent would be to reverse merge with a large pharmaceutical company once …

Accesswire.com

Category:  Pharmaceutical Detail Drugs


Immune Pharmaceuticals (NASDAQ:IMNP) - Stocks Newswire

(2 days ago) Immune Pharmaceuticals (NASDAQ:IMNP) is pushing forward with a multi-pronged way to deal with battling malignancy. Over the previous year, it has essentially extended its immuno-oncology (I/O) senior initiative to drive this exertion forward.

Stocksnewswire.com

Category:  Pharmaceutical Detail Drugs


Immune Pharmaceuticals Inc. (IMNPQ) Stock Price Today

(7 days ago) A high-level overview of Immune Pharmaceuticals Inc. (IMNPQ) stock. Stay up to date on the latest stock price, chart, news, analysis, …

Seekingalpha.com

Category:  Pharmaceutical Detail Drugs


Immune Pharmaceuticals Inc - Company Profile and News

(9 days ago) Immune Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company provides novel therapeutic agents for the treatment of immunologic and inflammatory diseases.

Bloomberg.com

Category:  Pharmaceutical Detail Drugs


IMMUNE PHARMACEUTICALS INC (IMNPQ) Company Profile & …

(6 days ago) Immune Pharmaceuticals, Inc. was founded in 2010 and is based in Fort Lee, New Jersey. On April 2, 2020, the voluntary petition of Immune Pharmaceuticals, Inc. along with its …

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Immune Pharmaceuticals Inc (IMNPQ) Stock Price, Quote

(1 days ago) Immune Pharmaceuticals Inc (IMNPQ) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Nasdaq.com

Category:  Pharmaceutical Detail Drugs


Pharmaceutical and Prescription Medicine Products

(2 days ago) A New Treatment for Auto-immune Conditions . Centocor, now part of Janssen Biotech Inc., introduces REMICADE ®, a prescription medication used to treat many auto-immune conditions, including Crohn’s disease, ulcerative colitis, rheumatoid arthritis and plaque psoriasis.

Jnj.com

Category:  Health Detail Drugs


IMMUNE PHARMACEUTICALS INC (IMNPQ) Stock Forum

(8 days ago) Find the latest IMMUNE PHARMACEUTICALS INC (IMNPQ) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Acquisition of Immune Pharmaceuticals - Bloomberg

(9 days ago) Immune Pharmaceuticals Inc has today received an unconditional offer by United General LTD. (UK) to acquire control of Immune Pharmaceuticals Inc.'s public company. The intent would be to reverse

Bloomberg.com

Category:  Pharmaceutical Detail Drugs


Immune Pharmaceuticals Inc (IMNPQ) News Headlines Nasdaq

(6 days ago) Immune Pharmaceuticals Inc (IMNPQ) Nasdaq Listed. Nasdaq 100. Data is currently not available. $0.004. +0.0035 (+700%) Aug 12, 2021 13:55. Add to Watchlist. Add to Portfolio.

Nasdaq.com

Category:  Pharmaceutical Detail Drugs


Ivermectin, ‘Wonder drug’ from Japan: the human use

(3 days ago) Onchocerciasis. The origins of ivermectin as a human drug are inextricably linked with Onchocerciasis (or River Blindness), a chronic human filarial disease caused by infection with Onchocerca volvulus worms. The parasites are transmitted via the bite of infected blackflies of the genus Simulium, which breed in highly-oxygenated, fast-flowing rivers and watercourses.

Ncbi.nlm.nih.gov

Category:  Health Detail Drugs


Acquisition of Immune Pharmaceuticals Nasdaq

(5 days ago) Immune Pharmaceuticals Inc' s, has received an unconditional offer to take over the public company. Immune Pharmaceuticals Inc has today received an unconditional offer by United General LTD. to

Nasdaq.com

Category:  Pharmaceutical Detail Drugs


IMNPQ.PK - Immune Pharmaceuticals Inc Profile Reuters

(2 days ago) Immune Pharmaceuticals Inc., is a clinical-stage biopharmaceutical company. It is engaged in the development of novel targeted therapeutic agents in the fields of immunology, inflammation

Reuters.com

Category:  Pharmaceutical Detail Drugs


Immune Pharmaceuticals News Markets Insider

(6 days ago) Immune Pharma Files For Chapter 11 Bankruptcy. Reuters 1,227d. BRIEF-Immune Pharmaceuticals Says Board Will Not Pursue Spin-Off Of Cytovia Unit. Marketwired 1,261d. Immune Pharmaceuticals

Markets.businessinsider.com

Category:  Pharmaceutical Detail Drugs


Immune Therapeutics LinkedIn

(2 days ago) Immune Therapeutics is a specialty pharmaceutical company involved in the manufacturing, distribution and marketing of our novel patented therapies to …

Linkedin.com

Category:  Pharmaceutical Detail Drugs


IMNPQ: Immune Pharmaceuticals Inc Stock Price Quote - OTC

(Just Now) Stock analysis for Immune Pharmaceuticals Inc (IMNPQ:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Bloomberg.com

Category:  Pharmaceutical Detail Drugs


IMNPQ Stock News IMMUNE PHARMACEUTICALS Stock Price

(4 days ago) Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a

Markets.businessinsider.com

Category:  Pharmaceutical Detail Drugs


IMMUNE PHARMACEUTICALS AKTIE News Aktienkurs

(Just Now) IMMUNE PHARMACEUTICALS AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Immune Pharmaceuticals Inc Registered Shs A2DQB0 IMNPQ US45254C2008

Finanzen.net

Category:  Pharmaceutical Detail Drugs


Immune Pharmaceuticals lists in US, Sweden after reverse

(5 days ago) Immune Pharmaceuticals hopes to use part of the proceeds from future financing to expand its R&D laboratory in Jerusalem. Immune Pharmaceuticals Ltd., a developer of treatments for inflammatory diseases and cancer expects to close within days a reverse merger with US pain and cancer treatment developer EpiCept Corporation (Nasdaq; OMX: EPCT) . The merged …

En.globes.co.il

Category:  Pharmaceutical,  Cancer Detail Drugs


IMNPQ Immune Pharmaceuticals Inc. SEC Filings MarketWatch

(1 days ago) Immune Pharmaceuticals Inc. SEC filings breakout by MarketWatch. View the IMNPQ U.S. Securities and Exchange Commission reporting information.

Marketwatch.com

Category:  Pharmaceutical Detail Drugs


Immune Pharmaceuticals And Bertilimumab: A Work In

(7 days ago) Immune Pharmaceuticals is an Israeli biopharmaceutical company that is developing innovative humanized monoclonal antibodies for the treatment of inflammatory and immunologic diseases.

Seekingalpha.com

Category:  Pharmaceutical Detail Drugs


Israel’s Immune Pharma waves the white flag after failing

(4 days ago) An eosinophil regulating drug that’s traveled down a winding path to the clinic is once again set to switch hands. Immune Pharma, which first in-licensed bertilimumab for immunologic and

Endpts.com

Category:  Health Detail Drugs


IMNP: Immune Pharmaceuticals Inc Stock Price Quote - Bloomberg

(9 days ago) Stock analysis for Immune Pharmaceuticals Inc (IMNP) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Bloomberg.com

Category:  Pharmaceutical Detail Drugs


What's Happening With These Drug Makers Stocks? -- Immune

(1 days ago) Immune Pharmaceuticals On Monday, shares in Englewood Cliffs, New Jersey headquartered Immune Pharmaceuticals Inc. rose 0.35%, ending the day at $0.71 . The stock recorded a trading volume of

Prnewswire.com

Category:  Pharmaceutical Detail Drugs


Acquisition of Immune Pharmaceuticals - AP NEWS

(7 days ago) Immune Pharmaceuticals Inc has today received an unconditional offer by United General LTD. (UK) to acquire control of Immune Pharmaceuticals Inc.’s public company. The intent would be to reverse merge with a large pharmaceutical company once …

Apnews.com

Category:  Pharmaceutical Detail Drugs


IMNPQ - Immune Pharmaceuticals Inc Stock quote - …

(9 days ago) Find real-time IMNPQ - Immune Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.

Money.cnn.com

Category:  Pharmaceutical Detail Drugs


Delta does not appear to make children sicker; Secondary

(9 days ago) Healthcare & Pharmaceuticals But the immune system response to infection appears to outshine its response to vaccines when it comes to memory B cells. Regardless of whether antibodies are

Reuters.com

Category:  Pharmaceutical,  Health Detail Drugs


Delving Deep into Immune Pharmaceuticals Diverse Pipeline

(5 days ago) Immune Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focusing on the treatment of immuno-inflammatory diseases and cancer. The company has several active clinical programs, led by bertilimumab, which is in Phase 2 for the treatment of inflammatory bowel disease and skin disorders. Analyst Jason Napodano digs into the …

Streetwisereports.com

Category:  Pharmaceutical,  Cancer Detail Drugs


New Jersey drugmaker files for bankruptcy

(3 days ago) Immune Pharmaceuticals, a New Jersey-based biopharmaceutical company specializing in the development of treatments for immunologic and inflammatory diseases, filed for Chapter 11 bankruptcy Feb. 19.

Beckershospitalreview.com

Category:  Pharmaceutical Detail Drugs


Immune Pharmaceuticals Signs License & Research Agreement

(8 days ago) Immune Pharmaceuticals Inc. applies a personalized approach to treating and, developing novel, highly-targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and

Prnewswire.com

Category:  Pharmaceutical Detail Drugs


EpiCept Corporation (IMNP) Stock Price - Seeking Alpha

(6 days ago) Immune Pharmaceuticals and Vector Therapeutics sign option agreement for worldwide Ceplene rights SA News Tue, Nov. 27, 2018. Immune Pharmaceuticals misses by $0.16 SA News Sun, Nov. 25, 2018.

Seekingalpha.com

Category:  Pharmaceutical Detail Drugs

Filter Type: